Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy

被引:51
作者
Chen, William C. [1 ]
Magill, Stephen T. [2 ]
Wu, Ashley [1 ]
Vasudevan, Harish N. [1 ]
Morin, Olivier [1 ]
Aghi, Manish K. [2 ]
Theodosopoulos, Philip V. [2 ]
Perry, Arie [2 ,3 ]
McDermott, Michael W. [2 ]
Sneed, Penny K. [1 ]
Braunstein, Steve E. [1 ]
Raleigh, David R. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA
关键词
atypical meningioma; MIB1; radiation; radiotherapy; oncology; CENTRAL-NERVOUS-SYSTEM; GROSS-TOTAL RESECTION; PROGNOSTIC-FACTORS; RADIATION-THERAPY; ANAPLASTIC MENINGIOMAS; SURGICAL RESECTION; UNITED-STATES; PRIMARY BRAIN; TUMORS; CLASSIFICATION;
D O I
10.3171/2017.9.JNS171609
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE The goal of this study was to investigate the impact of adjuvant radiotherapy (RT) on local recurrence and overall survival in patients undergoing primary resection of atypical meningioma, and to identify predictive factors to inform patient selection for adjuvant RT. METHODS One hundred eighty-two patients who underwent primary resection of atypical meningioma at a single institution between 1993 and 2014 were retrospectively identified. Patient, meningioma, and treatment data were extracted from the medical record and compared using the Kaplan-Meier method, log-rank tests, multivariate analysis (MVA) Cox proportional hazards models with relative risk (RR), and recursive partitioning analysis. RESULTS The median patient age and imaging follow-up were 57 years (interquartile range [IQR] 45-67 years) and 4.4 years (IQR 1.8-7.5 years), respectively. Gross-total resection (GTR) was achieved in 114 cases (63%), and 42 patients (23%) received adjuvant RT. On MVA, prognostic factors for death from any cause included GTR (RR 0.4, 95% CI 0.1-0.9, p = 0.02) and MIB1 labeling index (LI) <= 7% (RR 0.4, 95% CI 0.1-0.9, p = 0.04). Prognostic factors on MVA for local progression included GTR (RR 0.2, 95% CI 0.1-0.5, p = 0.002), adjuvant RT (RR 0.2, 95% CI 0.1-0.4, p < 0.001), MIB1 LI <= 7% (RR 0.2, 95% CI 0.1-0.5, p < 0.001), and a remote history of prior cranial RT (RR 5.7, 95% CI 1.3-18.8, p = 0.03). After GTR, adjuvant RT (0 of 10 meningiomas recurred, p = 0.01) and MIB1 LI <= 7% (RR 0.1, 95% CI 0.003-0.3, p < 0.001) were predictive for local progression on MVA. After GTR, 2.2% of meningiomas with MIB1 LI <= 7% recurred (1 of 45), compared with 38% with MIB1 LI > 7% (13 of 34; p < 0.001). Recursive partitioning analysis confirmed the existence of a cohort of patients at high risk of local progression after GTR without adjuvant RT, with MIB1 LI > 7%, and evidence of brain or bone invasion. After subtotal resection, adjuvant RT (RR 0.2, 95% CI 0.04-0.7, p = 0.009) and <= 5 mitoses per 10 hpf (RR 0.1, 95% CI 0.03-0.4, p = 0.002) were predictive on MVA for local progression. CONCLUSIONS Adjuvant RT improves local control of atypical meningioma irrespective of extent of resection. Although independent validation is required, the authors' results suggest that MIB1 LI, the number of mitoses per 10 hpf, and brain or bone invasion may be useful guides to the selection of patients who are most likely to benefit from adjuvant RT after resection of atypical meningioma.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 42 条
[1]   LONG-TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION [J].
Aghi, Manish K. ;
Carter, Bob S. ;
Cosgrove, Garth R. ;
Ojemann, Robert G. ;
Amin-Hanjani, Sepideh ;
Martuza, Robert L. ;
Curry, William T., Jr. ;
Barker, Fred G., II .
NEUROSURGERY, 2009, 64 (01) :56-60
[2]   Extent of Resection and Overall Survival for Patients With Atypical and Malignant Meningioma [J].
Aizer, Ayal A. ;
Bi, Wenya Linda ;
Kandola, Manjinder S. ;
Lee, Eudocia Q. ;
Nayak, Lakshmi ;
Rinne, Mikael L. ;
Norden, Andrew D. ;
Beroukhim, Rameen ;
Reardon, David A. ;
Wen, Patrick Y. ;
Al-Mefty, Ossama ;
Arvold, Nils D. ;
Dunn, Ian F. ;
Alexander, Brian M. .
CANCER, 2015, 121 (24) :4376-4381
[3]   Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma [J].
Aizer, Ayal A. ;
Arvold, Nils D. ;
Catalano, Paul ;
Claus, Elizabeth B. ;
Golby, Alexandra J. ;
Johnson, Mark D. ;
Al-Mefty, Ossama ;
Wen, Patrick Y. ;
Reardon, David A. ;
Lee, Eudocia Q. ;
Nayak, Lakshmi ;
Rinne, Mikael L. ;
Beroukhim, Rameen ;
Weiss, Stephanie E. ;
Ramkissoon, Shakti H. ;
Abedalthagafi, Malak ;
Santagata, Sandro ;
Dunn, Ian F. ;
Alexander, Brian M. .
NEURO-ONCOLOGY, 2014, 16 (11) :1547-1553
[4]  
Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231
[5]   Adjuvant radiotherapy for atypical meningiomas [J].
Bagshaw, Hilary P. ;
Burt, Lindsay M. ;
Jensen, Randy L. ;
Suneja, Gita ;
Palmer, Cheryl A. ;
Couldwell, William T. ;
Shrieve, Dennis C. .
JOURNAL OF NEUROSURGERY, 2017, 126 (06) :1822-1828
[6]   Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma [J].
Bruna, Jordi ;
Brell, Marta ;
Ferrer, Isidre ;
Gimenez-Bonafe, Pepita ;
Tortosa, Avelina .
NEUROPATHOLOGY, 2007, 27 (02) :114-120
[7]   Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO [J].
Clark, Victoria E. ;
Erson-Omay, E. Zeynep ;
Serin, Akdes ;
Yin, Jun ;
Cotney, Justin ;
Oezduman, Koray ;
Avsar, Timuin ;
Li, Jie ;
Murray, Phillip B. ;
Henegariu, Octavian ;
Yilmaz, Saliha ;
Guenel, Jennifer Moliterno ;
Carrion-Grant, Geneive ;
Yilmaz, Baran ;
Grady, Conor ;
Tanrikulu, Bahattin ;
Bakircioglu, Mehmet ;
Kaymakcalan, Hande ;
Caglayan, Ahmet Okay ;
Sencar, Leman ;
Ceyhun, Emre ;
Atik, A. Fatih ;
Bayri, Yasar ;
Bai, Hanwen ;
Kolb, Luis E. ;
Hebert, Ryan M. ;
Omay, S. Bulent ;
Mishra-Gorur, Ketu ;
Choi, Murim ;
Overton, John D. ;
Holland, Eric C. ;
Mane, Shrikant ;
State, Matthew W. ;
Bilguevar, Kaya ;
Baehring, Joachim M. ;
Gutin, Philip H. ;
Piepmeier, Joseph M. ;
Vortmeyer, Alexander ;
Brennan, Cameron W. ;
Pamir, M. Necmettin ;
Kilic, Tuerker ;
Lifton, Richard P. ;
Noonan, James P. ;
Yasuno, Katsuhito ;
Guenel, Murat .
SCIENCE, 2013, 339 (6123) :1077-1080
[8]  
Commins Deborah L, 2007, Neurosurg Focus, V23, pE3
[9]  
Davis FG, 2001, NEURO-ONCOLOGY, V3, P152, DOI 10.1093/neuonc/3.3.152
[10]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247